OrphanDrug
OrphanDrug
Pharma Knowledge Base

cutaneous collagenous vasculopathy

ORPHA: 280779

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

Cutaneous collagenous vasculopathy (CCV) is a primary microangiopathy confined to the skin, characterized by multiple and widespread telangiectasias

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with cutaneous collagenous vasculopathy, sourced from HPO and Orphanet clinical annotations.

Diffuse telangiectasiaPetechiaeBruising susceptibilitySkin rashProminent superficial blood vesselsErythemaVascular skin abnormalityMaculeAbnormality of metabolism/homeostasisPruritus

Classification & Codes

Orphanet Code

ORPHA:280779
cutaneous collagenous vasculopathy
OrphanetORPHA:280779
Treatments0 drug(s)
Symptoms on record10 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO